Risk stratification in acute coronary syndromes is essential to target early invasive strategies and aggressive antithrombotic therapies to high-risk patients who benefit most.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wenaweser et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: